Jiaohong Biotech Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Jiaohong Biotech General Information
Description
Developer of clinical diagnostic kits, automated diagnostic equipment and key raw materials intended to promote the development of the industry. The company has developed a number of diagnostic technologies, its products can be widely used in the fields of precise diagnosis of tumors, nucleic acid detection of epidemic viruses, nucleic acid detection of animal and plant diseases, and food safety, enabling its clients to use accurate diagnosis products.
Contact Information
Website
www.jiaohbio.comCorporate Office
- 3rd Floor, Building C
- No. 930 Jianchuan Road, Minhang District
- Shanghai
- China
Corporate Office
- 3rd Floor, Building C
- No. 930 Jianchuan Road, Minhang District
- Shanghai
- China
Jiaohong Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 19-Jan-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 05-Aug-2021 | Completed | Startup |
Jiaohong Biotech Patents
Jiaohong Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023169228-A1 | Novel thermophilic endonuclease mutant, and preparation method therefor and application thereof | Inactive | 11-Mar-2022 | ||
| JP-2022530483-A | Detection technique system and use to concentrate low abundance dna mutations based on nuclease cooperative pcr principles | Active | 22-Apr-2019 | ||
| JP-7384459-B2 | Detection technology system and use for enriching low abundance dna mutations based on nuclease cooperative pcr principles | Active | 22-Apr-2019 | ||
| EP-3998352-A1 | Detection technology system for enriching low-abundance dna mutation on the basis of nuclease-coupled pcr principle and application thereof | Inactive | 22-Apr-2019 | ||
| EP-3998352-A4 | Detection technology system for enriching low-abundance dna mutation on the basis of nuclease-coupled pcr principle and application thereof | Inactive | 22-Apr-2019 | C12Q1/6858 |
Jiaohong Biotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Furong Capital | Growth/Expansion | Minority | ||
| Prosperico Ventures | Venture Capital | Minority | ||
| Guangzhou Wondfo Biotech | Corporation | Minority |
Jiaohong Biotech FAQs
-
When was Jiaohong Biotech founded?
Jiaohong Biotech was founded in 2021.
-
Where is Jiaohong Biotech headquartered?
Jiaohong Biotech is headquartered in Shanghai, China.
-
What industry is Jiaohong Biotech in?
Jiaohong Biotech’s primary industry is Diagnostic Equipment.
-
Is Jiaohong Biotech a private or public company?
Jiaohong Biotech is a Private company.
-
What is Jiaohong Biotech’s current revenue?
The current revenue for Jiaohong Biotech is .
-
How much funding has Jiaohong Biotech raised over time?
Jiaohong Biotech has raised $1.08M.
-
Who are Jiaohong Biotech’s investors?
Furong Capital, Prosperico Ventures, and Guangzhou Wondfo Biotech have invested in Jiaohong Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process